Protagenic Therapeutics, Inc. (PTIX)

NASDAQ: PTIX · IEX Real-Time Price · USD

0.765

-0.175 (-18.62%)

At close: Jul 2, 2024, 4:00 PM

0.803

+0.038 (4.99%)

After-hours: Jul 2, 2024, 4:38 PM EDT

Protagenic Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1998
Selling, General & Admin	1.21	1.97	3	1.85	1.28	Upgrade
Research & Development	3.32	1.59	1.14	0.7	0.81	Upgrade
Operating Expenses	4.53	3.56	4.14	2.55	2.09	Upgrade
Operating Income	-4.53	-3.56	-4.14	-2.55	-2.09	Upgrade
Interest Expense / Income	0.11	0.14	0.5	0.25	0.02	Upgrade
Other Expense / Income	0.37	-0.14	-0.11	-0.25	-0.35	Upgrade
Pretax Income	-5	-3.56	-4.52	-2.55	-1.75	Upgrade
Net Income	-5	-3.56	-4.52	-2.55	-1.75	Upgrade
Shares Outstanding (Basic)	4	4	4	3	3	Upgrade
Shares Outstanding (Diluted)	4	4	4	3	3	Upgrade
Shares Change	0.62%	17.17%	42.57%	0.76%	-	Upgrade
EPS (Basic)	-1.15	-0.82	-1.24	-1.00	-0.68	Upgrade
EPS (Diluted)	-1.15	-0.82	-1.24	-1.00	-0.68	Upgrade
Free Cash Flow	-3.85	-2	-2.8	-1.35	-0.49	Upgrade
Free Cash Flow Per Share	-0.89	-0.46	-0.76	-0.52	-0.19	Upgrade
EBITDA	-4.86	-3.42	-4.03	-2.3	-1.73	Upgrade
Depreciation & Amortization	0.03	0	0	0	0	Upgrade
EBIT	-4.89	-3.42	-4.03	-2.3	-1.74	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).